PEN Q3 2020 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena

PENPenumbra, Inc.

$13B

Q3 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$151M+8.3% YoY

Gross Profit

$91M60.2% margin

Operating Income

-$20M-13.3% margin

Net Income

-$9M-5.8% margin

EPS (Diluted)

$-0.24

QoQ Revenue Growth

+43.7%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$8M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$810M

Total Liabilities

$191M

Stockholders' Equity

$622M

Cash & Equivalents

$80M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$151M	$140M	+8.3%
Gross Profit	$91M	$96M	-5.3%
Operating Income	-$20M	$13M	-255.3%
Net Income	-$9M	$11M	-176.8%

Revenue Segments

Neuro

$76M50%

Peripheral Vascular

$75M50%

Geographic Segments

UNITED STATES

$110M73%

Other Non-US

$41M27%